We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Bacterial Blood Infections Tied to Heightened Colon Cancer Risk

By LabMedica International staff writers
Posted on 12 May 2020
Colorectal cancer occurs in the colon or the rectum and it is the third most common type of cancer in the USA. More...
Around 90% of cases occur in people aged 50 years or older. As well as age, risk factors include a family history of colorectal cancer, some genetic syndromes, obesity, and a lack of exercise, a diet low in fruit and vegetables, and inflammatory bowel disease.

Anaerobic bacteria, unlike aerobic bacteria, do not require oxygen in order to function. They are a normal part of the human body, existing in various locations, including the gut. They usually do not cause infections, but when they do, it is most often in the area that the bacteria inhabit. A new study indicates that there is an association between blood infections caused by certain types of bacteria and an increased risk of colon cancer.

A team of scientists associated with Odense University Hospital (Odense, Denmark) gathered data on 45,760 blood infections, including information about the type of pathogens present in the participants’ bloodstreams. Of the 45,760 people who had a bacterial blood infection, 492 (1.1%) later developed colorectal cancer. Of these, 241 (0.5%) were within the first year of the bacterial blood infection. The team matched each of these people by age and sex to a control group of five people who had not had a blood infection.

The investigators reported that compared to people with blood infections caused by aerobic bacteria such as Escherichia coli or Staphylococcus aureus or people without blood infections, those anaerobic bacteria associated with an increased risk of colorectal cancer were: Clostridium septicum (tied to a 42-times increased risk within a year after a blood infection, and a 21-times higher risk overall); and Bacteroides ovatus, (tied to a 13-times increased risk within a year after a blood infection, and a six times higher risk overall).

Ulrik Stenz Justesen, MD, a Clinical Microbiologist and senior author of the study, said, “At this stage we are not sure if the bacteria are directly causing cases of colorectal cancer, or if the blood infection with these bacteria is itself caused by the cancer. It's an example of the question 'is this the chicken or the egg? With regards to screening, if we saw these high risk bacteria in combination with advanced age, then it would definitely be worth screening the person for colorectal cancer.” The study was slated to be presented at the European Congress of Clinical Microbiology and Infectious Diseases which was to be held Apr 18 - 21, 2020 in Paris, France.

Related Links:
Odense University Hospital


Gold Member
Neonatal Heel Incision Device
Tenderfoot
Online QC Software
Acusera 24•7
Multi-Chamber Washer-Disinfector
WD 390
HPV Test
Allplex HPV28 Detection
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The approach supports myocardial infarction diagnosis in resource-limited settings by reducing delays between clinical suspicion and biochemical confirmation (Image Credit: Adobe Stock)

Portable Troponin Assay Brings Heart Attack Diagnosis Closer to Patients

Timely confirmation of myocardial infarction often depends on laboratory testing that may not be immediately available at the point of care. This gap between clinical suspicion and definitive evidence... Read more

Molecular Diagnostics

view channel
Image: The Co-Dx PCR platform combines real-time PCR quality with a lower-cost instrument and consumable model to facilitate deployment near the patient (Photo courtesy of Co-Diagnostics, Inc.)

Point-of-Care Multiplex PCR Test Submitted to FDA for Flu A/B and RSV Detection

Co-Diagnostics, Inc. (Co-Dx; Salt Lake City, UT, USA) has submitted the Co-Dx PCR Flu A/B & RSV upper respiratory multiplex test for use on the Co-Dx PCR Pro instrument through a Dual 510(k) premarket... Read more

Microbiology

view channel
Image: An innovative countywide program in Taiwan combines risk-based screening with decentralized community care to improve hepatitis C detection and treatment (Image Credit: iStock)

Precision Screening Helps Close Hepatitis C Diagnosis and Treatment Gaps

Hepatitis C remains a leading cause of cirrhosis and liver cancer, yet many infections go undiagnosed or untreated because health systems fail to reach those at greatest risk. Although highly effective... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.